Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.79B | 10.54B | 10.13B | 8.56B | 6.17B | 6.11B |
Gross Profit | 5.18B | 5.05B | 4.84B | 4.21B | 2.96B | 2.87B |
EBITDA | 1.42B | 1.57B | 1.20B | 1.59B | 869.20M | 878.00M |
Net Income | 320.70M | 538.80M | 226.70M | 369.70M | 224.30M | 246.10M |
Balance Sheet | ||||||
Total Assets | 9.35B | 8.05B | 8.02B | 7.07B | 5.16B | 4.35B |
Cash, Cash Equivalents and Short-Term Investments | 946.30M | 1.15B | 1.58B | 1.31B | 964.40M | 465.90M |
Total Debt | 3.78B | 2.61B | 2.45B | 2.37B | 2.10B | 2.03B |
Total Liabilities | 6.51B | 5.18B | 5.39B | 4.73B | 3.67B | 3.06B |
Stockholders Equity | 2.41B | 2.46B | 2.12B | 1.93B | 1.24B | 1.22B |
Cash Flow | ||||||
Free Cash Flow | 630.20M | 611.30M | 735.00M | 1.02B | 938.30M | 683.60M |
Operating Cash Flow | 1.16B | 1.14B | 1.08B | 1.27B | 1.06B | 854.00M |
Investing Cash Flow | -1.33B | -543.50M | -320.90M | -848.10M | -334.70M | -261.70M |
Financing Cash Flow | -291.10M | -1.01B | -479.20M | -83.60M | -239.70M | -371.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £4.65B | 9.61 | 18.22% | 1.09% | 2.85% | 61.98% | |
76 Outperform | £14.63B | 20.39 | 46.76% | 2.63% | 11.42% | -7.03% | |
71 Outperform | £6.82B | 23.14 | 10.25% | 1.12% | 6.87% | 22.36% | |
69 Neutral | £2.85B | 9.70 | 16.46% | ― | -6.82% | -37.46% | |
62 Neutral | $16.76B | 11.38 | -7.38% | 2.96% | 1.59% | -23.30% | |
60 Neutral | £4.50B | 77.34 | -7.28% | 4.85% | -17.08% | -128.46% | |
48 Neutral | £263.88M | ― | -96.36% | ― | -16.32% | -202.39% |